lunes, 10 de septiembre de 2018

NHLBI Funding & Research Opportunities and Announcements for August 24, 2018

NHLBI_Standard_Sig_Logo_RGB - New

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices

Notice to Extend the Expiration Date for PAR-16-021 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)"
(NOT-HL-18-645)
National Heart, Lung, and Blood Institute
Notice of Correction to Funding Opportunity Description and Application and Submission Information in RFA-HL-19-005 Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required)
(NOT-HL-18-646)
National Heart, Lung, and Blood Institute

Requests for Applications

Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional)
(RFA-RM-18-031)
Office of Strategic Coordination (Common Fund)
Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional)
(RFA-RM-18-032)
Office of Strategic Coordination (Common Fund)
Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Pain from Musculoskeletal Trauma (UM1 Clinical Trial Optional)
(RFA-RM-18-033)
Office of Strategic Coordination (Common Fund)
Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain (UM1 Clinical Trial Optional)
(RFA-RM-18-034)
Office of Strategic Coordination (Common Fund)
Clinical Coordination Center for Common Fund Acute to Chronic Pain Signatures (A2CPS) Program (U24 Clinical Trial Optional)
(RFA-RM-18-035)
Office of Strategic Coordination (Common Fund)

Program Announcements

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(PA-18-906)

National Heart, Lung, and Blood Institute

No hay comentarios: